Genocea Biosciences

Graphic image of a graveyard with tombstones a full moon and a raven perched on a branch

The 2022 Biotech Graveyard

Biotech's tumbling market has proven especially perilous, and, for many companies, clinical disappointments were followed by financial dead ends and closures.

Max Bayer Nov 21, 2022 3:00am

titan Atlas Greek methology world crushing crumble

Genocea moves to sell itself, cut 65% of workforce

Apr 29, 2022 9:49am

Genocea to drop late-phase herpes drug, cut headcount

Sep 26, 2017 9:30am